Molecular Characterization of Invasive Meningococcal Isolates from Countries in the African Meningitis Belt before Introduction of a Serogroup A Conjugate Vaccine

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Caugant, Dominique A ^a,b   Kristiansen, Paul A ^a   Wang, Xin ^c   Mayer, Leonard W ^c   Taha, Muhamed Kheir ^d   Ouédraogo, Rasmata ^e   Kandolo, Denis ^f   Bougoudogo, Flabou ^g   Sow, Samba ^h   Bonte, Laurence ⁱ  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d INSTITUT PASTEUR   (France)

^e Centre Hospitalier Universitaire Pediatrique Charles de Gaulle   (Burkina Faso)

^f World Health Organization Ouagadougou   (Burkina Faso)

^g Institut National de Recherche en Sante Publique Mali   (Mali)

^h Centre pour les Vaccins en Développement CVD   (Mali)

ⁱ MÉDECINS SANS FRONTIÈRES   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ADENYLATE KINASE; AMOXICILLIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; FETA PROTEIN; FUMARATE HYDRATASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; MENINGOCOCCUS VACCINE; OUTER MEMBRANE PROTEIN; OXIDOREDUCTASE; PENICILLIN G; PHOSPHOGLUCOMUTASE; PORIN A; PYRUVATE DEHYDROGENASE; RIFAMPICIN; SHIKIMATE DEHYDROGENASE; SULFONAMIDE; TETRACYCLINE; UNCLASSIFIED DRUG;

ABCZ GENE; ADK GENE; AFRICA; ANALYTIC METHOD; ANTIBIOTIC SENSITIVITY; AROE GENE; ARTICLE; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERIUM ISOLATE; BURKINA FASO; FETA GENE; FUMC GENE; GDH GENE; GENETIC VARIABILITY; HOUSEKEEPING GENE; KENYA; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NEISSERIA MENINGITIDIS; NONHUMAN; PATHOGENESIS; PDHC GENE; PORA GENE; UGANDA;

AFRICA SOUTH OF THE SAHARA; ANTI-BACTERIAL AGENTS; GENETIC VARIATION; HUMANS; MENINGOCOCCAL INFECTIONS; NEISSERIA MENINGITIDIS; PORINS; SEROTYPING;

EID: 84866926975     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046019     Document Type: Article

References (36)

1. Lapeyssonie L, (1963) La meningite cerebrospinale en Afrique. Bull World Health Organ 28 (Suppl.) (): 3-114.
2. Molesworth AM, Thomson MC, Connor SJ, Cresswell MP, Morse AP, et al. (2002) Where is the Meningitis Belt? Defining an area at risk of epidemic meningitis in Africa. Trans R Soc Trop Med Hyg 96: 242-249.
3. Boisier P, Nicolas P, Djibo S, Taha M-K, Jeanne I, et al. (2007) Meningococcal meningitis: Unprecedented incidence of serogroup X-related cases in 2006 in Niger. Clin Infect Dis 44: 657-663.
4. Collard JM, Maman Z, Yacouba H, Djibo S, Nicolas P, et al. (2010) Increase in Neisseria meningitidis serogroup W135, Niger, 2010. Emerg Infect Dis 16: 1496-1498.
5. Denis F, Rey JL, Amadou A, Saliou P, Prince-David M, et al. (1982) Emergence of meningococcal meningitis caused by W 135 subgroup in Africa. Lancet 2: 1335-1336.
6. Djibo S, Nicolas P, Alonso J-M, Djibo A, Couret D, et al. (2003) Outbreaks of serogroup X meningococcal meningitis in Niger 1995-2000. Trop Med Int Health 8: 1118-1123.
7. Koumare B, Ouedraogo-Traore R, Sanou I, Yada AA, Sow I, et al. (2007) The first large epidemic of meningococcal disease caused by serogroup W135, Burkina Faso, 2002. Vaccine 25: A37-A41.
8. Materu S, Cox HS, Isaakidis P, Baruani B, Ogaro T, et al. (2007) Serogroup X in meningococcal disease, Western Kenya. Emerg Infect Dis 13: 944-945.
9. Mayer LW, Reeves MW, Al-Hamdan N, Sacchi CT, Taha MK, et al. (2002) Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex. J Infect Dis 185: 1596-1605.
10. Nathan N, Rose AM, Legros D, Tiendrebeogo SR, Bachy C, et al. (2007) Meningitis serogroup W135 outbreak, Burkina Faso, 2002. Emerg Infect Dis 13: 920-923.
11. Nicolas P, Djibo S, Sidikou F, Tenebray B, Stor R, et al. (2006) Epidemics caused by group X meningoccal meningitis in Africa in 2006. Med Trop 66: 494.
12. Pollard AJ, Santamaria M, Maiden MCJ, Nicolas P, Handford S, et al. (2003) W135 Meningococcal Disease in Africa. Emerg Infect Dis 9: 1503-1504.
13. Taha M-K, Du Chatelet IP, Schlumberger M, Sanou I, Djibo S, et al. (2002) Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger. J Clin Microbiol 40: 1083-1084.
14. Greenwood B, (1999) Manson Lecture. Meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg 93: 341-353.
15. Tikhomirov E, Santamaria M, Esteves K, (1997) Meningococcal disease: Public health burden and control. World Health Stat Q 50: 170-177.
16. Nicolas P, Chippaux JP, Martet G, (1996) Epidemic of meningococcal meningitis in Africa in 1996: current data. Med Trop (Mars) 56: 203-204.
17. Riou J-Y, Djibo S, Sangare L, Lombart J-P, Fagot P, et al. (1996) A predictable comeback: The second pandemic of infections caused by Neisseria meningitidis serogroup A subgroup III in Africa, 1995. Bull World Health Organ 74: 1996-181.
18. Nicolas P, Norheim G, Garnotel E, Djibo S, Caugant DA, (2005) Molecular epidemiology of Neisseria meningitidis isolated in the African meningitis belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes. J Clin Microbiol 43: 5129-5135.
19. Reingold AL, Broome CV, Hightower AW, (1985) Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine. Lancet 2: 114-118.
20. World Health Organization (2000) Detecting meningococcal meningitis epidemics in highly-endemic African countries. Wkly Epidemiol Rec 75: 306-309.
21. LaForce FM, Konde K, Viviani S, Preziosi MP, (2007) The Meningitis Vaccine Project. Vaccine 25: A97-A100.
22. LaForce FM, Okwo-Bele J-M, (2011) Eliminating epidemic group A meningococcal meningitis in Africa through a new vaccine. Health Aff (Millwood) 30: 1049-1057.
23. Ajello GW, Feeley JC, Hayes PS, Reingold AL, Bolan G, et al. (1984) Trans-isolate medium: a new medium for primary culturing and transport of Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. J Clin Microbiol 20: 55-58.
24. Craven DE, Frasch CE, Robbins JB, Feldman HA, (1978) Serogroup identification of Neisseria meningitidis: comparison of an antiserum agar method with bacterial slide agglutination. J Clin Microbiol 7: 410-414.
25. Katz LS, Bolen CR, Harcourt BH, Schmink S, Wang X, et al. (2009) Meningococcus genome informatics platform: A system for analyzing multilocus sequence typing data. Nucleic Acids Res 37: W606-W611.
26. Russell JE, Jolley KA, Feavers IM, Maiden MCJ, Suker J, (2004) PorA variable regions of Neisseria meningitidis. Emerg Infect Dis 10: 674-678.
27. Thompson EAL, Feavers IM, Maiden MCJ, (2003) Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component. Microbiology 149: 1849-1858.
28. Kristiansen PA, Diomande F, Wei SC, Ouedraogo R, Sangare L, et al. (2011) Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine. Clin Vaccine Immunol 18: 435-443.
29. R-project website. Available: http://www.R-project.org. Accessed 2012 Feb 14.
30. WHO Website. Available: http://www.who.int/csr/disease/meningococcal/epidemiological/en/index.html. Accessed 2012 July 4.
31. Bai X, Borrow R, (2010) Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccine. Expert Rev Vaccines 9: 1203-1217.
32. Jolley KA, Brehony C, Maiden MCJ, (2007) Molecular typing of meningococci: recommendations for target choice and nomenclature. FEMS Microbiol Rev 31: 89-96.
33. Ouedraogo-Traore R, Hoiby EA, Sanou I, Sangare L, Kyelem N, et al. (2002) Molecular characteristics of Neisseria meningitidis strains isolated in Burkina Faso in 2001. Scand J Infect Dis 34: 804-807.
34. Raghunathan PL, Jones JD, Tiendrebeogo SR, Sanou I, Sangare L, et al. (2006) Predictors of immunity after a major serogroup W-135 meningococcal disease epidemic, Burkina Faso, 2002. J Infect Dis 193: 607-616.
35. Delrieu I, Yaro S, Tamekloé TSA, Njanpop-Lafourcade B-M, Tall H, et al. (2011) Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso. PLoS ONE 6: e19513.
36. Findlow H, Vogel U, Mueller JE, Curry A, Njanpop-Lafourcade B-M, et al. (2007) Three cases of invasive meningococcal disease caused by a capsule null locus strain circulating among healthy carriers in Burkina Faso. J Infect Dis 195: 1071-1077.